Roberto Butera
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Multicomponent Synthesis of Heterocycles 3
- Click Chemistry and Applications 1
- Synthesis and Characterization of Heterocyclic Compounds 1
- Synthesis of Tetrazole Derivatives 1
- Oncology 5
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Co-authors
- Alexander Dömlingꝉ (9 shared papers)Tad A. Holak (6 shared papers)Katarzyna Guzik (2 shared papers)Katarzyna Magiera‐Mularz (5 shared papers)Shabnam Shaabani (2 shared papers)Marcin D. Tomala (1 shared paper)Magdalena Konieczny (1 shared paper)Markella Konstantinidou (2 shared papers)
- Journals
- Molecules (2 papers)Journal of Medicinal Chemistry (1 paper)Chemical Communications (1 paper)Expert Opinion on Therapeutic Patents (1 paper)The Journal of Organic Chemistry (1 paper)
- Partner nations
- NetherlandsPolandCzechia
In The Last Decade
Roberto Butera
9 papers receiving 331 citations
Peers
Comparison fields: 5 of 45
- Oncology 198
- Immunology 86
- Organic Chemistry 66
- Biological Psychiatry 5
- Computational Theory and Mathematics 35
Countries citing papers authored by Roberto Butera
This map shows the geographic impact of Roberto Butera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Butera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Butera more than expected).
Fields of papers citing papers by Roberto Butera
This network shows the impact of papers produced by Roberto Butera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Butera. The network helps show where Roberto Butera may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Butera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 119 | |
| 2 | 2018 | 119 | |
| 3 | 2021 | 46 | |
| 4 | 2019 | 17 | |
| 5 | 2020 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 5 | |
| 8 | 2020 | 4 | |
| 9 | 2024 | 1 |
About Roberto Butera
Roberto Butera is a scholar working on Organic Chemistry, Oncology, Molecular Biology, Hematology and Immunology, having authored 9 papers that have together received 332 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Multicomponent Synthesis of Heterocycles (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Click Chemistry and Applications (1 paper), Synthesis and Characterization of Heterocyclic Compounds (1 paper), Synthesis of Tetrazole Derivatives (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (198 citations), Immunology (86 citations), Organic Chemistry (66 citations), Biological Psychiatry (5 citations) and Computational Theory and Mathematics (35 citations). Roberto Butera has collaborated with scholars based in Netherlands, Poland and Czechia. Frequent co-authors include Alexander Dömlingꝉ, Tad A. Holak, Katarzyna Guzik, Katarzyna Magiera‐Mularz, Shabnam Shaabani, Marcin D. Tomala, Magdalena Konieczny, Markella Konstantinidou, Hans W. Nijman and Philip H. Elsinga. Their work appears in journals such as Molecules, Journal of Medicinal Chemistry, Chemical Communications, Expert Opinion on Therapeutic Patents and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.